Erythrodermic presentation of psoriasis in a patient treated with dupilumab
Sign Up to like & getrecommendations! Published in 2018 at "JAAD Case Reports"
DOI: 10.1016/j.jdcr.2018.05.014
Abstract: IL: interleukin Th: T-helper D upilumab is an interleukin (IL)-4 receptor a (IL-4Ra) antagonist that inhibits IL-4 and IL13 signaling, keymediators of T-helper (Th) 2-mediated inflammation. Whereas an immune shift toward Th2 drives atopic dermatitis… read more here.
Keywords: erythrodermic presentation; patient treated; treated dupilumab; psoriasis patient ... See more keywords
Onset of vitiligo in a psoriasis patient on ixekizumab
Sign Up to like & getrecommendations! Published in 2021 at "Dermatologic Therapy"
DOI: 10.1111/dth.15102
Abstract: Vitiligo is an acquired skin disorder clinically characterized by hypopigmentated macules and patches. Psoriasis is a chronic‐inflammatory‐skin‐condition characterized by erythematous‐plaques covered with scales particularly over the extensor‐surfaces, scalp, and lumbosacral region. Recent major‐researches‐advancements have significantly… read more here.
Keywords: vitiligo psoriasis; psoriasis patient; onset vitiligo; psoriasis ... See more keywords
Appearance of lentigines in psoriasis patient treated with guselkumab.
Sign Up to like & getrecommendations! Published in 2019 at "Dermatology online journal"
DOI: 10.5070/d3251042619
Abstract: Development of lentigines in areas of resolving psoriatic plaques is a rare phenomenon that has been reported following various treatment modalities including phototherapy, topical therapies, and biologics. Although the exact mechanism is unknown, evidence suggests… read more here.
Keywords: lentigines psoriasis; patient treated; appearance lentigines; psoriasis patient ... See more keywords